This product is a synthesized chemical reagent intended solely for in vitro laboratory research and analytical testing
Closed on December 25, 2024, and January 1, 2025
As CagriSema is a fixed dose combination, it is a regulatory requirement to demonstrate that the combination is safe and effective for the target population and provides added benefit over the individual components, a spokesperson for Novo Nordisk explained for Medical News Today
Clinical evidence suggests minimal additional benefitapproximately 12 kg beyond semaglutide alone, according to meta-analyses
Inside the study The new work was led at Rutgers University by Daniel Semenza, director of research at the New Jersey Gun Violence Research Center and an associate professor at the School of Public Health, along with Christopher Thomas, an assistant professor at its Camden campus
2.4% among those reporting no/low distress) and while usage levels were similar across social grades interest in using drugs to support weight loss in future was greater among more typically disadvantaged groups (among whom obesity is more prevalent)